ExodusPoint Capital Management’s CureVac CVAC Stock Holding History

ExodusPoint Capital Management’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-49,554	Closed	-$137K	–	1554
2025 Q1	$137K	Buy	+49,554	New	+$172K	﹤0.01%	1330
2024 Q3	–	Sell	-24,356	Closed	-$83K	–	1706
2024 Q2	$83K	Sell	24,356 -230,808	-90%	-$755K	﹤0.01%	1433
2024 Q1	$773K	Buy	255,164 +235,698	+1,211%	+$827K	0.01%	1026
2023 Q4	$82K	Buy	+19,466	New	+$106K	﹤0.01%	1365
2022 Q3	–	Sell	-11,995	Closed	-$163K	–	1947
2022 Q2	$163K	Sell	11,995 -19,809	-62%	-$328K	﹤0.01%	1684
2022 Q1	$624K	Buy	+31,804	New	+$635K	0.01%	1405
2021 Q4	–	Sell	-25,348	Closed	-$1.39M	–	2228
2021 Q3	$1.39M	Buy	+25,348	New	+$1.53M	0.02%	879
2021 Q2	–	Sell	-2,496	Closed	-$228K	–	2434
2021 Q1	$228K	Buy	2,496 +1,946	+354%	+$189K	﹤0.01%	1822
2020 Q4	$45K	Buy	+550	New	+$42.1K	﹤0.01%	1875

Other funds holding CVAC

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

ExodusPoint Capital Management's CVAC Position: Q2 2025 in Review

ExodusPoint Capital Management sold out of CureVac (CVAC) in Q2 2025, closing a stake of 49,554 shares — an estimated $137K sold.

ExodusPoint Capital Management first reported a position in CVAC in Q4 2020 and held it in 9 quarters. The position peaked at $1.39M in Q3 2021. 91 funds tracked by Wall St. Rank hold CVAC as of Q2 2025.

ExodusPoint Capital Management reported no remaining CureVac position as of Q2 2025 after selling out during the quarter.
ExodusPoint Capital Management sold 49,554 CureVac shares in Q2 2025, an estimated $137K.
ExodusPoint Capital Management first reported a position in CureVac in Q4 2020 and held it in 9 quarters.
ExodusPoint Capital Management's CureVac position peaked at $1.39M in Q3 2021.
91 funds tracked by Wall St. Rank held CureVac as of Q2 2025.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.